Niveditha Mohan

Niveditha Mohan practices at UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center.

Niveditha Mohan's NPI, 1154422780, was assigned on September 26, 2006. Niveditha Mohan holds Pennsylvania license MD427940.

Niveditha Mohan's primary practice is UPMC Presbyterian, at 200 Lothrop Street, Pittsburgh, PA 15213 in Allegheny County. The practice phone is (412) 647-2345.

Niveditha Mohan's primary practice is UPMC Presbyterian in Pittsburgh, Pennsylvania, part of University of Pittsburgh Medical Center. Niveditha Mohan is also affiliated with Select Specialty Hospital - Pittsburgh / UPMC. The medical group on file is University of Pittsburgh Physicians, Department of Radiology. Dmand AI also links Niveditha Mohan to 5 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Niveditha Mohan practices, 8 sites in all. Vendor and product names are available with a free account.

Rheumatology is Niveditha Mohan's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Niveditha Mohan is licensed in Pennsylvania.

CMS data shows 167 Medicare services from Niveditha Mohan across 3 procedure codes in 2024, for 101 Medicare patients. Medicare paid $9,828 for them.

CMS counts 101 Medicare patients who saw Niveditha Mohan in 2024. The largest group is 65 to 74, with 52 patients. 75% of them have arthritis, and 66% have high blood pressure. Their average risk score is 1.74, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Niveditha Mohan's median patient age at 69, with 70% women.

In 2024, Niveditha Mohan wrote 2,177 Medicare Part D claims for 320 patients. 80% of them were for generic drugs. CMS names the drug for 1,889 of them, across 43 drugs with 11 or more claims each, at $1,848,813 in total drug cost. In 2023, CMS named 2,096 claims across 48 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 81 out of 100 for Niveditha Mohan for performance year 2024, reported as part of a group. Niveditha Mohan accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Niveditha Mohan as offering telehealth.

Dmand AI links 6 papers to Niveditha Mohan in 2013. The most frequent topics are Adverse Drug Reaction Reporting Systems, Antirheumatic Agents and Arthritis, Rheumatoid. Niveditha Mohan has published most often in Curr Rheumatol Rep. Niveditha Mohan's most frequent co-authors are Heidi J. Crayton, MD, Candace E. Hobson, MD and Gail S. Kerr, MD.

Dmand AI links Niveditha Mohan to 1 clinical trial. Conditions studied include Graves Ophthalmopathy and Exophthalmos.

CMS Open Payments shows 4 general payments to Niveditha Mohan from 4 drug and device companies from 2018 to 2022. Education make up the largest share, 59% of the total. GlaxoSmithKline, LLC. paid the most, $118.